Cough Assist Devices Market Analysis

Cough Assist Devices Market Analysis

Based on product type, the cough assist devices market is bifurcated into automatic cough assist device and manual cough assist device. The automatic cough assist device segment accounted for major revenue share and was valued at around USD 124.6 million in 2022. The high market growth is primarily attributed to parameters such as improved effectiveness, monitoring and data recording capabilities, homecare suitability, and ease of use among others. Automatic cough assist devices offer a user-friendly and convenient solution for individuals with impaired cough function. Automatic cough assist devices often come with adjustable pressure settings and timing options. This allows healthcare professionals to tailor the device to the specific needs of each individual. Thus, owing to above-mentioned variables, the market is expected to record robust growth over the forecast period.
 

Based on choice of delivery, the cough assist devices market is segmented into face mask, mouthpiece, and adapter. The mouthpiece segment held a majority revenue share in 2022 and is anticipated to reach over USD 190.3 million by 2032. Mouthpiece cough assist devices are relatively simple and easy to use. They consist of a mouthpiece that the individual can comfortably hold in their mouth and breathe through during the therapy. This design allows for greater accessibility and independence, as it eliminates the need for a mask or external equipment. Moreover, improved patient comfort, portability, and better hygienic considerations among other factors will further fuel the product adoption rate. Thus, all the above-mentioned factors are expected to boost the market growth over the forecast period.
 

Based on end-use, the cough assist devices market is segmented into hospitals, home care settings, and others. The home care settings segment held a significant revenue share in 2022 and is anticipated to witness fastest growth to reach over USD 161.4 million in 2032. Preference for personalized care, improved quality of life, reduced risk of infections and cost-effectiveness are the key attributes propelling the homecare segmental growth. Homecare cough assist devices can be a cost-effective alternative to hospital-based care as they allow individuals to receive respiratory care in the comfort and familiarity of their own homes.
 

Additionally, homecare cough assist devices may eliminate the need for caregiver assistance, reducing caregiving costs. Furthermore, hospital settings can be potential sources of infections, including healthcare-associated respiratory infections. By using cough assist devices at home, individuals can minimize their exposure to pathogens and reduce the risk of acquiring infections.
 

U.S. cough assist devices market is expected to reach around USD 134.5 million by 2032. Shift towards home-based care, technological advancements, increasing prevalence of respiratory conditions and reimbursement and insurance coverage in the U.S. are prime factors expected to drive the market growth. Adequate reimbursement and insurance coverage for cough assist devices have played a significant role in their adoption. The aging population is more susceptible to respiratory conditions. The U.S. has recorded a rising prevalence of respiratory conditions such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, and spinal cord injuries. These conditions often result in impaired cough function and the need for airway clearance assistance, thereby, driving the demand for cough assist devices. Therefore, the afore-mentioned factors are estimated to augment the regional market growth during the analysis period.